Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics

Rebecca L. McCloud, Caroline E. Franks, Sean T. Campbell, Benjamin W. Purow, Thurl E. Harris, Ku Lung Hsu

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Diacylglycerol kinases (DGKs) regulate lipid metabolism and cell signaling through ATP-dependent phosphorylation of diacylglycerol to biosynthesize phosphatidic acid. Selective chemical probes for studying DGKs are currently lacking and are needed to annotate isoform-specific functions of these elusive lipid kinases. Previously, we explored fragment-based approaches to discover a core fragment of DGK-α (DGKα) inhibitors responsible for selective binding to the DGKα active site. Here, we utilize quantitative chemical proteomics to deconstruct widely used DGKα inhibitors to identify structural regions mediating off-target activity. We tested the activity of a fragment (RLM001) derived from a nucleotide-like region found in the DGKα inhibitors R59022 and ritanserin and discovered that RLM001 mimics ATP in its ability to broadly compete at ATP-binding sites of DGKα as well as >60 native ATP-binding proteins (kinases and ATPases) detected in cell proteomes. Equipotent inhibition of activity-based probe labeling by RLM001 supports a contiguous ligand-binding site composed of C1, DAGKc, and DAGKa domains in the DGKα active site. Given the lack of available crystal structures of DGKs, our studies highlight the utility of chemical proteomics in revealing active-site features of lipid kinases to enable development of inhibitors with enhanced selectivity against the human proteome.

Original languageEnglish (US)
Pages (from-to)231-236
Number of pages6
Issue number2
StatePublished - Jan 16 2018
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics'. Together they form a unique fingerprint.

Cite this